GlobeNewswire
-
Rosedil Introduces Rosedil Capsules, a Biotin, Zinc and Horsetail Dietary Supplement for Hair Wellness Routines
19/11/2026 -
Livsayis™ (cemdisiran) Approved by the FDA as First and Only siRNA Therapy in Generalized Myasthenia Gravis and Only Treatment with Four-Times-a-Year Subcutaneous Dosing
19/11/2026 -
Pyxis Oncology to Host Live Webcast on Updated MICVO Phase 1 Monotherapy Data Demonstrating Durable Response in 2L+ R/M HNSCC Following Late-Breaking Oral Presentation at EORTC-NCI-AACR Symposium
19/11/2026 -
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
18/11/2026 -
Press Release: Sanofi’s Infilbray approved in the US as the first medicine to treat neurological manifestations of Type 3 Gaucher disease
18/11/2026 -
Communiqué de presse : Infilbray, de Sanofi, approuvé aux États-Unis comme le premier médicament indiqué dans le traitement des manifestations neurologiques de la maladie de Gaucher de type 3
18/11/2026 -
Teva Announces R&D Leadership Transition; Eric Hughes to Depart the Company
18/11/2026 -
Palvella Therapeutics to Host Webcast to Introduce New QTORIN™ Program
18/11/2026 -
MEDIROM Announces Receipt of Nasdaq Delisting Notice, Filing of Annual Report and Submission of Hearing Request
18/11/2026 -
His Choice Health Announces No Needle No Scalpel Vasectomy Clinic In Greenville, SC Opening January 7, 2027
18/11/2026 -
Onco360® Has Been Selected as a National Pharmacy Partner for PIMJETMI® (pimicotinib)
18/11/2026 -
Cytek Biosciences to Participate in Upcoming Investor Conferences
18/11/2026 -
InspireMD Announces First U.S. Commercial TCAR Procedures Using the FDA-Approved CGuard® Prime TransCarotid Stent System
18/11/2026 -
ProKidney Names Farah Ali, M.D., M.S., Chief Medical Officer
18/11/2026 -
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
18/11/2026 -
InnovAge Holding Corp. Resolves Civil Matter with U.S. Department of Justice & Participating States
18/11/2026 -
BillionToOne Responds to Inaccurate and Misleading Short Seller Report
18/11/2026 -
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
18/11/2026 -
PROCEPT BioRobotics® to Participate in the Piper Sandler 38th Annual Healthcare Conference on December 2, 2026
18/11/2026
Pages